Skip to main content
Erschienen in: European Radiology 4/2019

15.10.2018 | Head and Neck

Morphological MRI-based features provide pretreatment survival prediction in glioblastoma

verfasst von: Julián Pérez-Beteta, David Molina-García, Alicia Martínez-González, Araceli Henares-Molina, Mariano Amo-Salas, Belén Luque, Elena Arregui, Manuel Calvo, José M. Borrás, Juan Martino, Carlos Velásquez, Bárbara Meléndez-Asensio, Ángel Rodríguez de Lope, Raquel Moreno, Juan A. Barcia, Beatriz Asenjo, Manuel Benavides, Ismael Herruzo, Pedro C. Lara, Raquel Cabrera, David Albillo, Miguel Navarro, Luis A. Pérez-Romasanta, Antonio Revert, Estanislao Arana, Víctor M. Pérez-García

Erschienen in: European Radiology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

We wished to determine whether tumor morphology descriptors obtained from pretreatment magnetic resonance images and clinical variables could predict survival for glioblastoma patients.

Methods

A cohort of 404 glioblastoma patients (311 discoveries and 93 validations) was used in the study. Pretreatment volumetric postcontrast T1-weighted magnetic resonance images were segmented to obtain the relevant morphological measures. Kaplan-Meier, Cox proportional hazards, correlations, and Harrell’s concordance indexes (c-indexes) were used for the statistical analysis.

Results

A linear prognostic model based on the outstanding variables (age, contrast-enhanced (CE) rim width, and surface regularity) identified a group of patients with significantly better survival (p < 0.001, HR = 2.57) with high accuracy (discovery c-index = 0.74; validation c-index = 0.77). A similar model applied to totally resected patients was also able to predict survival (p < 0.001, HR = 3.43) with high predictive value (discovery c-index = 0.81; validation c-index = 0.92). Biopsied patients with better survival were well identified (p < 0.001, HR = 7.25) by a model including age and CE volume (c-index = 0.87).

Conclusions

Simple linear models based on small sets of meaningful MRI-based pretreatment morphological features and age predicted survival of glioblastoma patients to a high degree of accuracy. The partition of the population using the extent of resection improved the prognostic value of those measures.

Key Points

• A combination of two MRI-based morphological features (CE rim width and surface regularity) and patients’ age outperformed previous prognosis scores for glioblastoma.
• Prognosis models for homogeneous surgical procedure groups led to even more accurate survival prediction based on Kaplan-Meier analysis and concordance indexes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: Images Are More than Pictures, They Are Data. Radiology 278(2):563–577CrossRefPubMed Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: Images Are More than Pictures, They Are Data. Radiology 278(2):563–577CrossRefPubMed
3.
Zurück zum Zitat Narang S, Lehrer M, Yang D, Lee J, Rao A (2016) Radiomics in glioblastoma: current status, challenges and opportunities. Transl Cancer Res 5(4):383–397 Narang S, Lehrer M, Yang D, Lee J, Rao A (2016) Radiomics in glioblastoma: current status, challenges and opportunities. Transl Cancer Res 5(4):383–397
4.
Zurück zum Zitat Ellingson BM, Bendszus M, Sorensen AG, Pope WB (2014) Emerging techniques and technologies in brain tumor imaging. Neuro Oncol 16(7):12–23 Ellingson BM, Bendszus M, Sorensen AG, Pope WB (2014) Emerging techniques and technologies in brain tumor imaging. Neuro Oncol 16(7):12–23
5.
Zurück zum Zitat Ellingson BM (2015) Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics. Curr Neurol Neurosci Rep 15(1):506CrossRefPubMed Ellingson BM (2015) Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics. Curr Neurol Neurosci Rep 15(1):506CrossRefPubMed
6.
Zurück zum Zitat Pérez-Beteta J, Martínez-González A, Molina D et al (2017) Glioblastoma: Does the pretreatment geometry matter? A postcontrast T1 MRI-based study. Eur Radiol 27:1096–1104CrossRefPubMed Pérez-Beteta J, Martínez-González A, Molina D et al (2017) Glioblastoma: Does the pretreatment geometry matter? A postcontrast T1 MRI-based study. Eur Radiol 27:1096–1104CrossRefPubMed
7.
Zurück zum Zitat Abrol S, Kotrotsou A, Salem A, Zinn PO, Colen RR (2017) Radiomic phenotyping in brain cancer to unravel hidden information in medical images. Top Magn Reson Imaging 26(1):43–53 Abrol S, Kotrotsou A, Salem A, Zinn PO, Colen RR (2017) Radiomic phenotyping in brain cancer to unravel hidden information in medical images. Top Magn Reson Imaging 26(1):43–53
8.
Zurück zum Zitat Cui Y, Tha KK, Teresaka S et al (2016) Prognostic imaging biomarkers in glioblastoma: Development and independent validation on the basis of multiregion and quantitative analysis of MR images. Radiology 278(2):546–553CrossRefPubMed Cui Y, Tha KK, Teresaka S et al (2016) Prognostic imaging biomarkers in glioblastoma: Development and independent validation on the basis of multiregion and quantitative analysis of MR images. Radiology 278(2):546–553CrossRefPubMed
9.
Zurück zum Zitat Pérez-Beteta J, Molina-García D, Ortiz-Alhambra JA et al (2018) Tumor surface regularity at MR imaging predicts survival and response to surgery in patients with glioblastoma. Radiology 288(1):218–225 Pérez-Beteta J, Molina-García D, Ortiz-Alhambra JA et al (2018) Tumor surface regularity at MR imaging predicts survival and response to surgery in patients with glioblastoma. Radiology 288(1):218–225
10.
Zurück zum Zitat Cui Y, Ren S, Tha KK, Wu J, Shirato H, Li R (2017) Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma. Eur Radiol 27(9):3583–3592 Cui Y, Ren S, Tha KK, Wu J, Shirato H, Li R (2017) Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma. Eur Radiol 27(9):3583–3592
11.
Zurück zum Zitat Kickingereder P, Burth S, Wick A et al (2016) Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models. Radiology 280(3):880–889CrossRefPubMed Kickingereder P, Burth S, Wick A et al (2016) Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models. Radiology 280(3):880–889CrossRefPubMed
12.
Zurück zum Zitat Lao J, Chen Y, Li ZC et al (2017) A Deep Learning-Based Radiomics Model for Prediction of Survival in Glioblastoma Multiforme. Sci Rep 7(1):10353CrossRefPubMedPubMedCentral Lao J, Chen Y, Li ZC et al (2017) A Deep Learning-Based Radiomics Model for Prediction of Survival in Glioblastoma Multiforme. Sci Rep 7(1):10353CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Wangaryattawanich P, Hatami M, Wang J et al (2015) Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. Neuro Oncol 17(11):1525–1537CrossRefPubMedPubMedCentral Wangaryattawanich P, Hatami M, Wang J et al (2015) Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. Neuro Oncol 17(11):1525–1537CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Ingrisch M, Schneider MJ, Nörenberg D et al (2017) Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma. Invest Radiol 52(6):360–366CrossRefPubMed Ingrisch M, Schneider MJ, Nörenberg D et al (2017) Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma. Invest Radiol 52(6):360–366CrossRefPubMed
15.
Zurück zum Zitat Ellingson BM, Harris RJ, Woodworth DC et al (2017) Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials. Neuro Oncol 19(1):89–98CrossRefPubMed Ellingson BM, Harris RJ, Woodworth DC et al (2017) Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials. Neuro Oncol 19(1):89–98CrossRefPubMed
16.
Zurück zum Zitat Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996CrossRefPubMed Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996CrossRefPubMed
17.
Zurück zum Zitat Grabowsky MM, Recinos PF, Nowacki AS et al (2014) Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma. J Neurosurg 121:1115–1123CrossRef Grabowsky MM, Recinos PF, Nowacki AS et al (2014) Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma. J Neurosurg 121:1115–1123CrossRef
18.
Zurück zum Zitat Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C (2011) Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol 13(12):1339–1348 Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C (2011) Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol 13(12):1339–1348
19.
Zurück zum Zitat Chaichana KL, Jusue-Torres I, Lemos AM et al (2014) The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors? J Neurooncol 120(3):625–634CrossRefPubMedPubMedCentral Chaichana KL, Jusue-Torres I, Lemos AM et al (2014) The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors? J Neurooncol 120(3):625–634CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Li YM, Suki D, Hess K, Sawaya R (2016) The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? J Neurosurg 124(4):977–988 Li YM, Suki D, Hess K, Sawaya R (2016) The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? J Neurosurg 124(4):977–988
21.
Zurück zum Zitat Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:109–198CrossRef Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:109–198CrossRef
23.
Zurück zum Zitat Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. JAMA 247(1):2543–2546 Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. JAMA 247(1):2543–2546
24.
Zurück zum Zitat Cordova JS, Gurbani SS, Holder CA et al (2016) Semi-automated volumetric and morphological assessment of glioblastoma resection with fluorescence-guided surgery. Mol Imaging Biol 18:454–462CrossRefPubMedPubMedCentral Cordova JS, Gurbani SS, Holder CA et al (2016) Semi-automated volumetric and morphological assessment of glioblastoma resection with fluorescence-guided surgery. Mol Imaging Biol 18:454–462CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Molina D, Pérez-Beteta J, Martínez-González A et al (2017) Lack of robustness of textural measures obtained from 3D brain tumor MRIs impose a need for standardization. PLoS One 12(6):e0178843CrossRefPubMedPubMedCentral Molina D, Pérez-Beteta J, Martínez-González A et al (2017) Lack of robustness of textural measures obtained from 3D brain tumor MRIs impose a need for standardization. PLoS One 12(6):e0178843CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Pérez-García VM, Calvo GF, Belmonte-Beitia J, Diego D, Pérez-Romasanta L (2011) Bright solitary waves in malignant gliomas. Phys Rev E Stat Nonlin Soft Matter Phys 84:021921 Pérez-García VM, Calvo GF, Belmonte-Beitia J, Diego D, Pérez-Romasanta L (2011) Bright solitary waves in malignant gliomas. Phys Rev E Stat Nonlin Soft Matter Phys 84:021921
27.
Zurück zum Zitat Anderson AR, Weaver A, Cummings PT, Quaranta V (2006) Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127:905–915 Anderson AR, Weaver A, Cummings PT, Quaranta V (2006) Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127:905–915
28.
Zurück zum Zitat Martin M (2008) Comparing invasive species to metastatic cancers inspires new insights for modelers. J Natl Cancer Inst 100:88 Martin M (2008) Comparing invasive species to metastatic cancers inspires new insights for modelers. J Natl Cancer Inst 100:88
29.
Zurück zum Zitat Henker C, Kriesen T, Glass Ä, Schneider B, Piek J (2017) Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival. J Neurooncol 135:391–402 Henker C, Kriesen T, Glass Ä, Schneider B, Piek J (2017) Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival. J Neurooncol 135:391–402
30.
Zurück zum Zitat Gittleman H, Lim D, Kattan MW et al (2017) An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Neuro Oncol 19(5):669–677PubMed Gittleman H, Lim D, Kattan MW et al (2017) An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Neuro Oncol 19(5):669–677PubMed
31.
Zurück zum Zitat Chung C (2015) Imaging biomarkers in preclinical studies on brain tumors. In: Preedy V, Patel V (eds) Biomarkers in cancer. Biomarkers in disease: methods, discoveries and applications. Springer, Dordrecht Chung C (2015) Imaging biomarkers in preclinical studies on brain tumors. In: Preedy V, Patel V (eds) Biomarkers in cancer. Biomarkers in disease: methods, discoveries and applications. Springer, Dordrecht
33.
Zurück zum Zitat Grossmann P, Gutman DA, Dunn WD Jr, Holder CA, Aerts HJ (2016) Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma. BMC Cancer 16:611CrossRefPubMedPubMedCentral Grossmann P, Gutman DA, Dunn WD Jr, Holder CA, Aerts HJ (2016) Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma. BMC Cancer 16:611CrossRefPubMedPubMedCentral
Metadaten
Titel
Morphological MRI-based features provide pretreatment survival prediction in glioblastoma
verfasst von
Julián Pérez-Beteta
David Molina-García
Alicia Martínez-González
Araceli Henares-Molina
Mariano Amo-Salas
Belén Luque
Elena Arregui
Manuel Calvo
José M. Borrás
Juan Martino
Carlos Velásquez
Bárbara Meléndez-Asensio
Ángel Rodríguez de Lope
Raquel Moreno
Juan A. Barcia
Beatriz Asenjo
Manuel Benavides
Ismael Herruzo
Pedro C. Lara
Raquel Cabrera
David Albillo
Miguel Navarro
Luis A. Pérez-Romasanta
Antonio Revert
Estanislao Arana
Víctor M. Pérez-García
Publikationsdatum
15.10.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 4/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5758-7

Weitere Artikel der Ausgabe 4/2019

European Radiology 4/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.